HURN
Huron Consulting Group Inc. NASDAQ Listed Oct 13, 2004$124.78
Mkt Cap $2.1B
52w Low $112.45
16.6% of range
52w High $186.78
50d MA $130.67
200d MA $148.48
P/E (TTM)
21.8x
EV/EBITDA
17.6x
P/B
4.3x
Debt/Equity
1.0x
ROE
19.9%
P/FCF
16.5x
RSI (14)
—
ATR (14)
—
Beta
0.19
50d MA
$130.67
200d MA
$148.48
Avg Volume
323.8K
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, medical groups, and health plans. The Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. The Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.
550 West Van Buren Street · Chicago, IL 60607 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.58 | 1.73 | +9.5% | 132.22 | -6.3% | -9.2% | +3.9% | — | — | — | — |
| Feb 24, 2026 | AMC | 1.94 | 2.17 | +11.9% | 126.36 | +1.9% | +5.5% | +7.5% | -1.3% | +2.2% | +2.8% | — |
| Oct 28, 2025 | AMC | 1.88 | 2.10 | +11.7% | 152.48 | +2.3% | +11.2% | -2.5% | -0.6% | +0.8% | -0.5% | — |
| Jul 31, 2025 | AMC | 1.79 | 1.89 | +5.6% | 132.08 | -2.2% | -7.6% | +3.7% | +1.1% | +0.8% | +2.2% | — |
| Apr 29, 2025 | AMC | 1.16 | 1.68 | +44.8% | 135.94 | -4.1% | -0.8% | +4.5% | +4.6% | +0.6% | +0.6% | — |
| Feb 25, 2025 | AMC | 1.52 | 1.90 | +25.0% | 125.33 | +7.1% | +18.2% | +0.9% | +1.9% | -2.6% | -0.5% | — |
| Oct 29, 2024 | AMC | 1.57 | 1.68 | +7.0% | 104.99 | +4.5% | +10.6% | -0.4% | -0.6% | +2.7% | +1.8% | — |
| Jul 30, 2024 | AMC | 1.48 | 1.68 | +13.5% | 112.93 | -2.6% | -2.6% | +2.1% | -3.4% | -3.5% | -1.9% | — |
| Apr 30, 2024 | AMC | 0.89 | 1.23 | +38.2% | 93.24 | -3.4% | -6.6% | -1.6% | +0.8% | +0.7% | +0.8% | — |
| Feb 27, 2024 | AMC | 1.12 | 1.29 | +15.2% | 107.36 | -3.9% | -12.5% | +4.5% | +1.3% | -1.1% | -1.1% | — |
| Nov 2, 2023 | AMC | 1.18 | 1.39 | +17.8% | 99.54 | +7.5% | +1.9% | +1.6% | +0.0% | -0.4% | +1.8% | — |
| Jul 27, 2023 | AMC | 1.00 | 1.38 | +38.0% | 79.29 | +10.0% | +18.1% | +1.0% | +3.6% | +2.3% | +0.9% | — |
| May 2, 2023 | AMC | 0.66 | 0.87 | +31.8% | 85.16 | +1.2% | -12.0% | -4.7% | +2.6% | +4.8% | +2.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 | Wedbush | Maintains | Outperform → Outperform | — | $181.34 | $181.12 | -0.1% | +1.0% | +0.1% | +0.1% | +1.0% | -1.1% |
| Jan 5 | Barrington Research | Maintains | Outperform → Outperform | — | $171.05 | $170.89 | -0.1% | +5.8% | -1.6% | +0.7% | -0.4% | +1.6% |
| Dec 24 | Benchmark | Maintains | Buy → Buy | — | $178.20 | $179.37 | +0.7% | +1.0% | +0.3% | -0.7% | -2.2% | -1.4% |
| Nov 14 | Truist | Maintains | Buy → Buy | — | $161.77 | $162.36 | +0.4% | +2.3% | -3.0% | +0.3% | +0.9% | +0.4% |
| Oct 29 | Benchmark | Maintains | Buy → Buy | — | $152.48 | $156.00 | +2.3% | +11.2% | -2.5% | -0.6% | +0.8% | -0.5% |
| Aug 7 | Barrington Research | Maintains | Outperform → Outperform | — | $128.91 | $129.10 | +0.1% | +2.2% | +1.0% | -1.4% | +0.8% | +3.6% |
| May 5 | Barrington Research | Maintains | Outperform → Outperform | — | $147.36 | $146.15 | -0.8% | +0.6% | +0.6% | +1.0% | +1.0% | -1.2% |
| Mar 27 | Barrington Research | Maintains | Outperform → Outperform | — | $142.51 | $142.53 | +0.0% | +0.1% | -0.3% | +0.8% | +2.0% | +1.0% |
| Mar 26 | Benchmark | Maintains | Buy → Buy | — | $145.00 | $145.79 | +0.5% | -1.7% | +0.1% | -0.3% | +0.8% | +2.0% |
| Mar 26 | Wedbush | Maintains | Outperform → Outperform | — | $145.00 | $145.79 | +0.5% | -1.7% | +0.1% | -0.3% | +0.8% | +2.0% |
| Mar 4 | Truist | Maintains | Buy → Buy | — | $148.42 | $148.61 | +0.1% | -0.5% | +0.2% | -1.6% | +2.6% | -3.4% |
| Feb 27 | Barrington Research | Maintains | Outperform → Outperform | — | $148.18 | $149.08 | +0.6% | +0.9% | +1.9% | -2.6% | -0.5% | +0.2% |
| Feb 26 | Truist | Maintains | Buy → Buy | — | $125.33 | $134.25 | +7.1% | +18.2% | +0.9% | +1.9% | -2.6% | -0.5% |
| Feb 26 | Benchmark | Maintains | Buy → Buy | — | $125.33 | $134.25 | +7.1% | +18.2% | +0.9% | +1.9% | -2.6% | -0.5% |
| Nov 4 | Barrington Research | Maintains | Outperform → Outperform | — | $115.07 | $115.70 | +0.5% | +2.7% | +1.8% | +6.5% | -0.4% | -0.2% |
| Oct 30 | Benchmark | Maintains | Buy → Buy | — | $104.99 | $109.76 | +4.5% | +10.6% | -0.4% | -0.6% | +2.7% | +1.8% |
| Sep 9 | Barrington Research | Maintains | Outperform → Outperform | — | $104.45 | $104.51 | +0.1% | +1.1% | -0.0% | -0.6% | +0.8% | +1.6% |
| Aug 5 | Barrington Research | Maintains | Outperform → Outperform | — | $108.51 | $106.02 | -2.3% | -3.5% | -1.9% | -0.5% | +0.9% | +0.4% |
| Jul 31 | Benchmark | Maintains | Buy → Buy | — | $112.93 | $110.00 | -2.6% | -2.6% | +2.1% | -3.4% | -3.5% | -1.9% |
| Jul 1 | Benchmark | Maintains | Buy → Buy | — | $98.50 | $99.16 | +0.7% | +0.1% | +0.6% | -1.6% | +0.4% | +0.2% |
| May 28 | Barrington Research | Maintains | Outperform → Outperform | — | $87.17 | $87.28 | +0.1% | +1.0% | -2.2% | -0.2% | +2.8% | +1.8% |
| May 16 | Truist | Maintains | Buy → Buy | — | $86.60 | $86.60 | +0.0% | +1.3% | -0.1% | -1.1% | -1.5% | -0.2% |
| May 13 | Benchmark | Maintains | Buy → Buy | — | $87.56 | $87.59 | +0.0% | -0.3% | -0.2% | -0.6% | +1.3% | -0.1% |
| May 6 | Barrington Research | Maintains | Outperform → Outperform | — | $86.32 | $86.60 | +0.3% | +0.7% | +0.8% | -0.7% | -0.1% | +0.6% |
| May 1 | Benchmark | Maintains | Buy → Buy | — | $93.24 | $90.06 | -3.4% | -6.6% | -1.6% | +0.8% | +0.7% | +0.8% |
| Mar 6 | Barrington Research | Maintains | Outperform → Outperform | — | $97.29 | $98.34 | +1.1% | +0.7% | +1.5% | -0.4% | +0.4% | -1.6% |
| Nov 29 | Truist | Maintains | Buy → Buy | — | $103.62 | $103.27 | -0.3% | -0.9% | +1.5% | +4.2% | -0.6% | -2.2% |
| Nov 27 | Truist | Maintains | Buy → Buy | — | $105.48 | $106.05 | +0.5% | -0.1% | -1.7% | -0.9% | +1.5% | +4.2% |
| Nov 8 | Barrington Research | Maintains | Outperform → Outperform | — | $103.07 | $102.60 | -0.5% | -0.4% | +1.8% | -0.0% | +3.7% | -0.0% |
| Sep 18 | Truist | Maintains | Buy → Buy | — | $99.07 | $100.34 | +1.3% | +3.4% | +0.7% | +2.3% | +0.5% | -3.6% |
| Aug 1 | Barrington Research | Maintains | Outperform → Outperform | — | $94.57 | $93.00 | -1.7% | +3.6% | +2.3% | +0.9% | -1.6% | +2.1% |
| Jul 28 | Benchmark | Maintains | Buy → Buy | — | $79.29 | $87.22 | +10.0% | +18.1% | +1.0% | +3.6% | +2.3% | +0.9% |
| May 25 | Barrington Research | Maintains | Outperform → Outperform | — | $83.18 | $82.77 | -0.5% | -3.1% | +1.4% | +0.3% | -0.8% | -0.7% |
| Mar 3 | Barrington Research | Maintains | Outperform → Outperform | — | $82.82 | $81.00 | -2.2% | -3.2% | -0.5% | -2.3% | -1.0% | +0.4% |
| Mar 2 | Truist | Maintains | Buy → Buy | — | $81.54 | $82.19 | +0.8% | +1.6% | -3.2% | -0.5% | -2.3% | -1.0% |
| Mar 1 | Benchmark | Maintains | Buy → Buy | — | $70.19 | $70.56 | +0.5% | +16.2% | +1.6% | -3.2% | -0.5% | -2.3% |
| Nov 2 | Barrington Research | Maintains | Outperform → Outperform | — | $73.04 | $75.00 | +2.7% | +3.8% | +2.5% | -3.2% | +1.8% | -1.1% |
| Aug 8 | Barrington Research | Maintains | Outperform → Outperform | — | $67.14 | $67.77 | +0.9% | -0.5% | +0.6% | -0.1% | -0.1% | +1.0% |
| Jul 29 | Truist | Maintains | Buy → Buy | — | $66.10 | $70.00 | +5.9% | +1.5% | +0.0% | +0.3% | -0.3% | -0.5% |
| May 4 | Benchmark | Maintains | Buy → Buy | — | $51.00 | $53.49 | +4.9% | +7.4% | -1.8% | -1.8% | +3.0% | +2.1% |
| Dec 18 | Benchmark | Upgrade | Hold → Buy | — | $53.30 | $54.87 | +2.9% | +8.1% | -3.0% | +0.8% | +1.5% | +0.3% |
| May 1 | Benchmark | Downgrade | Buy → Hold | — | $56.04 | $50.47 | -9.9% | -16.2% | -6.9% | +0.4% | -4.8% | +2.6% |
| Apr 20 | SunTrust Robinson Humphrey | Maintains | Buy → Buy | — | $49.47 | $48.18 | -2.6% | -3.4% | -1.4% | +1.9% | +1.4% | +2.4% |
| Jan 6 | SunTrust Robinson Humphrey | Maintains | Buy → Buy | — | $69.08 | $69.17 | +0.1% | +0.7% | -1.0% | -0.4% | +0.2% | +1.3% |
| Oct 30 | Benchmark | Maintains | Buy → Buy | — | $60.40 | $64.00 | +6.0% | +10.1% | -0.5% | +1.2% | +0.5% | -0.0% |
| Sep 3 | SunTrust Robinson Humphrey | Maintains | Buy → Buy | — | $61.21 | $61.63 | +0.7% | +1.8% | +2.0% | -1.1% | -1.1% | -0.3% |
| Aug 28 | Barrington Research | Upgrade | Market Perform → Outperform | — | $48.75 | $50.00 | +2.6% | +1.9% | -2.7% | +2.4% | +0.0% | +0.4% |
| Aug 1 | Benchmark | Upgrade | Hold → Buy | — | $43.65 | $45.85 | +5.0% | +4.2% | -1.0% | +3.0% | +1.3% | +1.2% |
| Sep 8 | William Blair | Upgrade | Market Perform → Outperform | — | $30.95 | $32.15 | +3.9% | +6.1% | -0.9% | +1.4% | -1.2% | +1.4% |
| May 23 | Benchmark | Maintains | Hold → Hold | — | $41.20 | $41.15 | -0.1% | -0.1% | +0.2% | +0.4% | +1.1% | -0.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | MCCARTNEY JOHNDir | — | Sell | 500 | $132.04 | $66K | 40,317 | -9.16% | — |
Data updated apr 25, 2026 2:24pm
· Source: massive.com